312 related articles for article (PubMed ID: 6112034)
1. Some in vitro and in vivo actions of the new histamine H2-receptor antagonist, ranitidine.
Daly MJ; Humphray JM; Stables R
Br J Pharmacol; 1981 Jan; 72(1):49-54. PubMed ID: 6112034
[TBL] [Abstract][Full Text] [Related]
2. A comparison of some of the pharmacological properties of etintidine, a new histamine H2-receptor antagonist, with those of cimetidine, ranitidine and tiotidine.
Cavanagh RL; Usakewicz JJ; Buyniski JP
J Pharmacol Exp Ther; 1983 Jan; 224(1):171-9. PubMed ID: 6129316
[TBL] [Abstract][Full Text] [Related]
3. A review of the animal pharmacology of ranitidine--a new, selective histamine H2-antagonist.
Brittain RT; Daly MJ
Scand J Gastroenterol Suppl; 1981 Jun; 69():1-9. PubMed ID: 6119770
[TBL] [Abstract][Full Text] [Related]
4. In vitro actions of ranitidine, a new histamine H2-receptor antagonist.
Daly MJ; Stables R
Agents Actions; 1980 Apr; 10(1 Pt 2):190-1. PubMed ID: 6104417
[TBL] [Abstract][Full Text] [Related]
5. Pharmacology of JB-9315, a new selective histamine H2-receptor antagonist.
Palacios B; Montero MJ; Sevilla MA; San Román L
Gen Pharmacol; 1998 Feb; 30(2):181-9. PubMed ID: 9502172
[TBL] [Abstract][Full Text] [Related]
6. The effect of ranitidine on gastric acid secretory response curves to histamine, pentagastrin or bethanechol in the dog with a Heidenhain pouch.
Daly MJ; Humphray JM; Bunce KT; Stables R
Agents Actions; 1981 Apr; 11(1-2):160-4. PubMed ID: 6113743
[TBL] [Abstract][Full Text] [Related]
7. Antagonism of vasodepressor and gastric secretory responses to histamine by the H2-receptor antagonists, ranitidine and cimetidine, in the anaesthetized dog.
Daly MJ; Humphray JM; Stables R
Br J Pharmacol; 1981 Jan; 72(1):55-60. PubMed ID: 6112035
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of gastric acid secretion in the dog by the H2-receptor antagonists, ranitidine, cimetidine, and metiamide.
Daly MJ; Humphray JM; Stables R
Gut; 1980 May; 21(5):408-12. PubMed ID: 6107261
[TBL] [Abstract][Full Text] [Related]
9. Pharmacology of mifentidine, a novel H2-receptor antagonist.
Pagani F; Micheletti R; Brambilla A; Schiavone A; Montagna E; Ciprandi C; Giachetti A
Arzneimittelforschung; 1985; 35(1A):451-5. PubMed ID: 2859036
[TBL] [Abstract][Full Text] [Related]
10. FR145715, a novel histamine H2 receptor antagonist, with specific anti-Helicobacter pylori activities.
Ishikawa H; Ito H; Higaki M; Higaki M; Matsumoto Y; Kamimura T; Katsura Y; Tomishi T; Inoue Y; Takasugi H; Tomoi M; Krakowka S; Yoshida K
Eur J Pharmacol; 1999 Aug; 378(3):299-310. PubMed ID: 10493106
[TBL] [Abstract][Full Text] [Related]
11. Activity of the new histamine H2-receptor antagonist zolantidine at cardiac and gastric H2-receptors.
Coruzzi G; Adami M; Pozzoli C; Poli E; Bertaccini G
Pharmacology; 1994 Feb; 48(2):69-76. PubMed ID: 7907797
[TBL] [Abstract][Full Text] [Related]
12. Kinetics and duration of action of ranitidine on gastric secretion and its effect on pancreatic secretion in duodenal ulcer patients.
Konturek SJ; Obtułowicz W; Kwiecień N; Kopp B; Oleksy J
Scand J Gastroenterol Suppl; 1981 Jun; 69():91-9. PubMed ID: 6119789
[TBL] [Abstract][Full Text] [Related]
13. Histamine H2-receptor antagonist action of ebrotidine. Effects on gastric acid secretion, gastrin levels and NSAID-induced gastrotoxicity in the rat.
Palop D; Agut J; Márquez M; Conejo L; Sacristán A; Ortiz JA
Arzneimittelforschung; 1997 Apr; 47(4A):439-46. PubMed ID: 9205740
[TBL] [Abstract][Full Text] [Related]
14. Effect of mifentidine on histamine-stimulated human atrium "in vitro": comparison with ranitidine and cimetidine.
Poli E; Medici D; Contini GA; Bertaccini G
Arch Int Pharmacodyn Ther; 1985 Feb; 273(2):221-5. PubMed ID: 2860879
[TBL] [Abstract][Full Text] [Related]
15. Pharmacology of ORF 17578, a new histamine H2-receptor antagonist: comparison with cimetidine and ranitidine.
Katz LB; Scott CK; Shriver DA
J Pharmacol Exp Ther; 1986 May; 237(2):404-10. PubMed ID: 2871172
[TBL] [Abstract][Full Text] [Related]
16. Effect of some new Histamine H2-receptor antagonists on the guinea-pig papillary muscle.
Bertaccini G; Coruzzi G
Naunyn Schmiedebergs Arch Pharmacol; 1981 Nov; 317(3):225-7. PubMed ID: 6119622
[TBL] [Abstract][Full Text] [Related]
17. Pharmacology of the novel H2 antagonist famotidine: in vitro studies.
Bertaccini G; Coruzzi G; Poli E; Adami M
Agents Actions; 1986 Nov; 19(3-4):180-7. PubMed ID: 2881455
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological comparison of ORF 17910, a potent, long-acting histamine H2-receptor antagonist, to cimetidine and ranitidine.
Katz LB; Scott CK; Shriver DA
J Pharmacol Exp Ther; 1986 Aug; 238(2):587-93. PubMed ID: 2874214
[TBL] [Abstract][Full Text] [Related]
19. [Effects of ranitidine, a new histamine H2-receptor antagonist, on secretagogue-stimulated gastric secretion in rats: comparison with cimetidine (author's transl)].
Okabe S; Kawakami M
Nihon Yakurigaku Zasshi; 1981 Aug; 78(2):57-62. PubMed ID: 6119281
[TBL] [Abstract][Full Text] [Related]
20. New ranitidine analogues containing the 2-aminobenzimidazole moiety: in vivo and in vitro histamine H2-receptor blocking activity.
Orsetti M; Oggero L
Agents Actions; 1988 Jun; 24(1-2):109-13. PubMed ID: 2900598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]